Complement control for COVID-19

Markus Bosmann
2021 Science immunology  
Excessive complement activation contributes to lung disease and adverse patient outcomes in COVID-19 (see the related Research Articles by Yan et al. and Ma et al.).
doi:10.1126/sciimmunol.abj1014 pmid:34035117 fatcat:e6itghl3mnf7vcfzbjc4cfrpae